People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kezar Life Sciences, Inc. | — | Biotechnology | Series C | $78.4M | $2.0B | 2017 |
Franklin J Berger at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Franklin J Berger on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John F. Fowler | 1 | 1 |
| Dr. Gerald J. Chan | 1 | 1 |
| Dr. Jean-Pierre J. Sommadossi | 1 | 1 |
| Christopher J. Kirk | 1 | 1 |
| Jean-Pierre J Sommadossi | 1 | 1 |
| Gerald J Chan | 1 | 1 |
| Michael J Kauffman | 1 | 1 |
| Bihua J Chen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.